Nathan Larson, DPM
Foot & Ankle Surgery · Bellingham, WANPI 1790030716
Payments from drug & device makers
Across 34 payments — averaging $21.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$104
- Triad Life Sciences Inc.$84
- Amgen$72
- AbbVie$61
- Smith+Nephew$57
- Treace Medical Concepts, Inc.$43
- plus $316 from 13 others
What the payments were for
- Food & beverage$737100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 4 | $104 |
| Triad Life Sciences Inc. | 2 | $84 |
| Amgen(2 entities) | 3 | $72 |
| AbbVie | 3 | $61 |
| Smith+Nephew | 3 | $57 |
| Treace Medical Concepts, Inc. | 2 | $43 |
| Mimedx Group, Inc. | 2 | $42 |
| Paragon 28, Inc. | 2 | $41 |
| Zimmer Biomet | 1 | $35 |
| KCI USA, Inc. | 2 | $30 |
| Orthofix Medical, Inc. | 2 | $29 |
| Nevro Corp. | 1 | $25 |
| Axogen | 1 | $20 |
| Summit Surgical Corp. | 1 | $20 |
| GRT US Holding, Inc. | 1 | $20 |
| Medtronic | 1 | $16 |
| Stryker | 1 | $15 |
| DJO, LLC | 1 | $12 |
| Fusion Orthopedics USA, LLC | 1 | $10 |
How this compares
$737 in reported general payments places this provider in the 35th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 106 | $1,019 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $556 |
| Cephalexin | 34 | $372 |
| Methylprednisolone | 28 | $177 |
| Amitriptyline Hcl | 15 | $158 |
| SsdSilver Sulfadiazine | 15 | $147 |
| Naproxen | 26 | $131 |
| Oxycodone Hcl | 31 | $128 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bellingham
- Thiran UdawattaBellingham$17K
- Jeffrey ChristensenEverett$884K
- David DalstromSeattle$497K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.